These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2565345)

  • 1. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
    Newman PJ; Derbes RS; Aster RH
    J Clin Invest; 1989 May; 83(5):1778-81. PubMed ID: 2565345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope.
    Flug F; Espinola R; Liu LX; SinQuee C; DaRosso R; Nardi M; Karpatkin S
    Blood; 1991 May; 77(9):1964-9. PubMed ID: 1708295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of functional recombinant epitopes for the platelet antigens, PlA1 and PlA2.
    Barron-Casella EA; Kickler TS; Rogers OC; Casella JF
    Blood; 1994 Aug; 84(4):1157-63. PubMed ID: 7519475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes.
    Goldberger A; Kolodziej M; Poncz M; Bennett JS; Newman PJ
    Blood; 1991 Aug; 78(3):681-7. PubMed ID: 1713513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system.
    Wang R; Furihata K; McFarland JG; Friedman K; Aster RH; Newman PJ
    J Clin Invest; 1992 Nov; 90(5):2038-43. PubMed ID: 1430225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes.
    Liu LX; Nardi M; Flug F; Karpatkin S
    Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
    Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A
    J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of a PlA1 epitope to the amino terminal 66 residues of platelet glycoprotein IIIa.
    Bowditch RD; Tani PH; Halloran CE; Frelinger AL; McMillan R; Ginsberg MH
    Blood; 1992 Feb; 79(3):559-62. PubMed ID: 1370635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa.
    Furihata K; Nugent DJ; Bissonette A; Aster RH; Kunicki TJ
    J Clin Invest; 1987 Dec; 80(6):1624-30. PubMed ID: 2445781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.
    Mikkelsson J; Perola M; Penttilä A; Goldschmidt-Clermont PJ; Karhunen PJ
    Atherosclerosis; 2001 Feb; 154(3):721-7. PubMed ID: 11257275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New polymorphism on platelet glycoprotein IIIa gene recognized by endonuclease Msp I: implications for PlA typing by allele-specific restriction analysis.
    Unkelbach K; Kalb R; Breitfeld C; Santoso S; Kiefel V; Mueller-Eckhardt C
    Transfusion; 1994 Jul; 34(7):592-5. PubMed ID: 7519794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system.
    Lyman S; Aster RH; Visentin GP; Newman PJ
    Blood; 1990 Jun; 75(12):2343-8. PubMed ID: 2350579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens.
    Kuijpers RW; Faber NM; Cuypers HT; Ouwehand WH; von dem Borne AE
    J Clin Invest; 1992 Feb; 89(2):381-4. PubMed ID: 1346615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dinucleotide deletion in exon 4 of the PlA2 allelic form of glycoprotein IIIa: implications for the correlation of serologic versus genotypic analysis of human platelet alloantigens.
    Skogen B; Wang R; McFarland JG; Newman PJ
    Blood; 1996 Nov; 88(10):3831-6. PubMed ID: 8916947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets.
    Liu LX; Nardi MA; Flug F; Karpatkin S
    Thromb Res; 1992 May; 66(4):309-20. PubMed ID: 1384161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response.
    Valentin N; Visentin GP; Newman PJ
    Blood; 1995 Jun; 85(11):3028-33. PubMed ID: 7756638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia.
    Noris P; Simsek S; de Bruijne-Admiraal LG; Porcelijn L; Huiskes E; van der Vlist GJ; van Leeuwen EF; van der Schoot CE; von dem Borne AE
    Blood; 1995 Aug; 86(3):1019-26. PubMed ID: 7620155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare leucine 40/arginine40 polymorphism on platelet glycoprotein IIIa is linked to the human platelet antigen 1b.
    Walchshofer S; Ghali D; Fink M; Panzer-Grümayer ER; Panzer S
    Vox Sang; 1994; 67(2):231-4. PubMed ID: 7801618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid 489 is encoded by a mutational "hot spot" on the beta 3 integrin chain: the CA/TU human platelet alloantigen system.
    Wang R; McFarland JG; Kekomaki R; Newman PJ
    Blood; 1993 Dec; 82(11):3386-91. PubMed ID: 7694683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.
    Addad F; Elalamy I; Chakroun T; Abderrazek F; Dridi Z; Hamdi S; Hassine M; Ben-Farhat M; Gerotziafas G; Hatmi M; Gamra H
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):674-8. PubMed ID: 20739877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.